Cone ERG Changes During Light Adaptation in Two All-Cone Mutant Mice: Implications for Rod-Cone Pathway Interactions.


Journal

Investigative ophthalmology & visual science
ISSN: 1552-5783
Titre abrégé: Invest Ophthalmol Vis Sci
Pays: United States
ID NLM: 7703701

Informations de publication

Date de publication:
01 08 2019
Historique:
entrez: 31 8 2019
pubmed: 31 8 2019
medline: 28 12 2019
Statut: ppublish

Résumé

The b-wave of the cone ERG increases in amplitude and speed during the first few minutes of adaptation to a rod-suppressing background light. Earlier studies implicate rod pathway input to the cone pathway in these changes. The timing and amplitude of the cone b-wave and isolated oscillatory potentials (OP) during the first 10 minutes of light adaptation in wild-type (WT) mice and two mutant lines without functional rods was examined: rhodopsin knockout (Rho-/-), lacking rod outer segments, and NRL knockout (Nrl-/-), in which rods are replaced by S-cones. Expression of the immediate-early gene c-fos, which is increased in the inner retina by light-induced activity, was evaluated by immunohistochemistry in dark- and light-adapted retinas. WT b-wave and OP amplitudes increased, and implicit times decreased during light adaptation. Subtracting OP did not alter b-wave changes. Rho-/- b-wave and OP amplitudes did not increase during adaptation. B-wave timing and amplitude and the timing of the major OP at 1 minute of adaptation were equivalent to WT at 10 minutes. The light-adapted ERG b-wave in Nrl-/- mice, which originates in both the rod and cone pathways, changed in absolute amplitude and timing similar to WT. C-fos expression was present in the inner retinas of dark-adapted Rho-/- but not WT or Nrl-/- mice. Activity in the distal rod pathway produces changes in the cone ERG during light adaptation. Rods in Rho-/- mice constitutively activate this rod-cone pathway interaction. The rod pathway S-cones in Nrl-/- mice may maintain the WT interaction.

Identifiants

pubmed: 31469895
pii: 2749491
doi: 10.1167/iovs.19-27242
pmc: PMC6716952
doi:

Substances chimiques

Basic-Leucine Zipper Transcription Factors 0
Eye Proteins 0
Nrl protein, mouse 0
Proto-Oncogene Proteins c-fos 0
Rhodopsin 9009-81-8

Types de publication

Journal Article Research Support, N.I.H., Intramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

3680-3688

Références

Doc Ophthalmol. 1992;79(4):363-9
pubmed: 1633746
Nat Genet. 2001 Dec;29(4):447-52
pubmed: 11694879
Biomed Res Int. 2016;2016:2790194
pubmed: 28101507
Vis Neurosci. 1992 Feb;8(2):145-50
pubmed: 1558826
Invest Ophthalmol Vis Sci. 2005 Jun;46(6):2156-67
pubmed: 15914637
Invest Ophthalmol Vis Sci. 1987 Nov;28(11):1816-23
pubmed: 3499417
Vision Res. 1972 May;12(5):889-907
pubmed: 4537671
Invest Ophthalmol Vis Sci. 1990 Feb;31(2):237-46
pubmed: 2303327
Mol Vis. 2009 Oct 30;15:2209-16
pubmed: 19898639
J Neurosci. 2004 Aug 25;24(34):7576-82
pubmed: 15329405
Vis Neurosci. 2006 Mar-Apr;23(2):155-67
pubmed: 16638169
Invest Ophthalmol Vis Sci. 1989 Apr;30(4):625-30
pubmed: 2703304
Neurosci Lett. 1993 Nov 12;162(1-2):9-11
pubmed: 8121644
Proc Natl Acad Sci U S A. 2000 Dec 5;97(25):13913-8
pubmed: 11095744
J Neurophysiol. 2011 May;105(5):2309-18
pubmed: 21389302
Vis Neurosci. 1999 Mar-Apr;16(2):391-8
pubmed: 10367972
Electroencephalogr Clin Neurophysiol. 1991 Jan;78(1):27-34
pubmed: 1701712
Invest Ophthalmol Vis Sci. 2004 Sep;45(9):3302-12
pubmed: 15326155
Vision Res. 1992 Nov;32(11):2049-53
pubmed: 1304082
Vision Res. 1972 May;12(5):875-88
pubmed: 5037708
Invest Ophthalmol Vis Sci. 1999 Oct;40(11):2633-7
pubmed: 10509660
Sci Rep. 2016 Jun 15;6:28086
pubmed: 27301998
J Comp Physiol Psychol. 1958 Feb;51(1):1-5
pubmed: 13513834
AMA Arch Ophthalmol. 1954 Apr;51(4):509-24
pubmed: 13137645
Nat Genet. 1997 Feb;15(2):216-9
pubmed: 9020854
J Gen Physiol. 2005 Mar;125(3):287-304
pubmed: 15738050
Prog Retin Eye Res. 1998 Oct;17(4):485-521
pubmed: 9777648
Invest Ophthalmol Vis Sci. 2004 Jun;45(6):2039-48
pubmed: 15161873
Brain Res Mol Brain Res. 1990 Jan;7(1):17-21
pubmed: 2153891
Vision Res. 2002 Jun;42(14):1715-25
pubmed: 12127105
J Neurosci. 2012 Jan 11;32(2):528-41
pubmed: 22238088
J Opt Soc Am. 1958 Apr;48(4):274
pubmed: 13526049
Invest Ophthalmol Vis Sci. 2006 Jun;47(6):2732-8
pubmed: 16723493
Can J Ophthalmol. 1987 Dec;22(7):354-61
pubmed: 3435853
Vis Neurosci. 2004 Nov-Dec;21(6):873-81
pubmed: 15733342
Brain Res Mol Brain Res. 1995 Mar;29(1):53-63
pubmed: 7770001

Auteurs

Ronald A Bush (RA)

National Institute on Deafness and Other Communication Disorders, National Institutes of Health, Bethesda, Maryland, United States.

Atsuhiro Tanikawa (A)

Department of Ophthalmology, Fujita Health University School of Medicine, Toyoake, Aichi, Japan.

Yong Zeng (Y)

National Institute on Deafness and Other Communication Disorders, National Institutes of Health, Bethesda, Maryland, United States.

Paul A Sieving (PA)

National Institute on Deafness and Other Communication Disorders, National Institutes of Health, Bethesda, Maryland, United States.
National Eye Institute, National Institutes of Health, Bethesda, Maryland, United States.

Articles similaires

Robotic Surgical Procedures Animals Humans Telemedicine Models, Animal

Odour generalisation and detection dog training.

Lyn Caldicott, Thomas W Pike, Helen E Zulch et al.
1.00
Animals Odorants Dogs Generalization, Psychological Smell
Animals TOR Serine-Threonine Kinases Colorectal Neoplasms Colitis Mice
Animals Tail Swine Behavior, Animal Animal Husbandry

Classifications MeSH